Treatment of severe progressive systemic sclerosis with transplantation of mesenchymal stromal cells from allogeneic related donors: Report of five cases

Arthritis and Rheumatism

Volumn 63, Issue 8, 2011, Pages 2540-2542

  Keyszer, Gernot ^a   Christopeit, Maximilian ^a   Fick, Sylvia ^a   Schendel, Marit ^a   Taute, Bettina Maria ^a   Behre, Gerhard ^a   Müller, Lutz Peter ^a   Schmoll, Hans Joachim ^a  

^a MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CITRATE SODIUM; CYCLOPHOSPHAMIDE; FRESH FROZEN PLASMA; HEPARIN; METHOTREXATE; PREDNISOLONE; SCL 70 ANTIBODY;

ACRAL NECROSIS; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; APHERESIS; ARTICLE; BONE MARROW; BONE MARROW BIOPSY; BONE MARROW MONONUCLEAR CELL; CLINICAL ARTICLE; CRYOPRESERVATION; DONOR; FEMALE; FORCED VITAL CAPACITY; HUMAN; ILIAC CREST; INFORMED CONSENT; LYMPHOCYTE SUBPOPULATION; MALE; MEDICAL ETHICS; MESENCHYMAL STEM CELL TRANSPLANTATION; MONONUCLEAR CELL; NECROSIS; PATIENT MONITORING; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SCORING SYSTEM; SEVERE PROGRESSIVE SYSTEMIC SCLEROSIS; SYSTEMIC SCLEROSIS;

ADULT; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; SCLERODERMA, DIFFUSE; STROMAL CELLS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 79961119978     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30431     Document Type: Article

References (14)

1. Tyndall A, Uccelli A,. Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks. Bone Marrow Transplant 2009; 43: 821-8.
2. Guiducci S, Distler O, Distler JH, Matucci-Cerinic M,. Mechanisms of vascular damage in SSc: implications for vascular treatment strategies. Rheumatology (Oxford) 2008; 47 Suppl 5: v18-20.
3. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O,. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003; 57: 11-20. (Pubitemid 38019084)
4. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, et al. Human mesenchymal stem cells modulate B-cell functions. Blood 2006; 107: 367-72. (Pubitemid 43053565)
5. Rasmusson I, Uhlin M, Le BK, Levitsky V,. Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes. J Leukoc Biol 2007; 82: 887-93. (Pubitemid 47511049)
6. Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R,. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 2003; 101: 2999-3001. (Pubitemid 36857986)
7. Zhou H, Guo M, Bian C, Sun Z, Yang Z, Zeng Y, et al. Efficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: clinical report. Biol Blood Marrow Transplant 2010; 16: 403-12.
8. Clements P, Lachenbruch P, Seibold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995; 22: 1281-5.
9. Fries JF, Spitz P, Kraines RG, Holman HR,. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137-45. (Pubitemid 10164318)
10. Christopeit M, Schendel M, Foll J, Muller LP, Keysser G, Behre G,. Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L. Leukemia 2008; 22: 1062-4. (Pubitemid 351689891)
11. Follansbee WP, Zerbe TR, Medsger TA Jr., Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association. Am Heart J 1993; 125: 194-203. (Pubitemid 23021644)
12. Breitbach M, Bostani T, Roell W, Xia Y, Dewald O, Nygren JM, et al. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 2007; 110: 1362-9. (Pubitemid 47281438)
13. Liang J, Zhang H, Hua B, Wang H, Lu L, Shi S, et al. Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Ann Rheum Dis 2010; 69: 1423-9.
14. Sun L, Wang D, Liang J, Zhang H, Feng X, Wang H, et al. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum 2010; 62: 2467-75.